Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock

38.855 EUR
+0.1 (+0.26%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

6

Overall QIA gets a fundamental rating of 6 out of 10. We evaluated QIA against 19 industry peers in the Life Sciences Tools & Services industry. QIA gets an excellent profitability rating and is at the same time showing great financial health properties. QIA has a decent growth rate and is not valued too expensively. With these ratings, QIA could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

QIA had positive earnings in the past year.
In the past year QIA had a positive cash flow from operations.
In the past 5 years QIA has always been profitable.
QIA had a positive operating cash flow in each of the past 5 years.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

With a decent Return On Assets value of 6.19%, QIA is doing good in the industry, outperforming 73.68% of the companies in the same industry.
QIA has a Return On Equity of 11.11%. This is in the better half of the industry: QIA outperforms 73.68% of its industry peers.
The Return On Invested Capital of QIA (7.44%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for QIA is below the industry average of 9.26%.
The last Return On Invested Capital (7.44%) for QIA is above the 3 year average (7.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROIC 7.44%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 19.58%, QIA belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
QIA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 27.02%, QIA belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
The Gross Margin of QIA (64.10%) is better than 94.74% of its industry peers.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
Industry RankSector Rank
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

QIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, QIA has less shares outstanding
QIA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, QIA has an improved debt to assets ratio.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.49 indicates that QIA is not in any danger for bankruptcy at the moment.
The Altman-Z score of QIA (3.49) is better than 63.16% of its industry peers.
QIA has a debt to FCF ratio of 4.50. This is a neutral value as QIA would need 4.50 years to pay back of all of its debts.
QIA has a better Debt to FCF ratio (4.50) than 73.68% of its industry peers.
QIA has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, QIA is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Altman-Z 3.49
ROIC/WACC0.91
WACC8.21%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

QIA has a Current Ratio of 2.60. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.60, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA's Quick ratio of 2.30 is amongst the best of the industry. QIA outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.3
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.18% over the past year.
QIA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.92% yearly.
The Revenue has been growing slightly by 5.32% in the past year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)8.18%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%

3.2 Future

The Earnings Per Share is expected to grow by 9.41% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y7.77%
EPS Next 2Y7.68%
EPS Next 3Y8.33%
EPS Next 5Y9.41%
Revenue Next Year4.96%
Revenue Next 2Y5.54%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

QIA is valuated rather expensively with a Price/Earnings ratio of 19.24.
73.68% of the companies in the same industry are more expensive than QIA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.51. QIA is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 17.62, which indicates a rather expensive current valuation of QIA.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than 68.42% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, QIA is valued a bit cheaper.
Industry RankSector Rank
PE 19.24
Fwd PE 17.62
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QIA is valued a bit cheaper than 68.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QIA is valued a bit cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.95
EV/EBITDA 13.35
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QIA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)2.43
EPS Next 2Y7.68%
EPS Next 3Y8.33%

1

5. Dividend

5.1 Amount

QIA has a yearly dividend return of 0.55%, which is pretty low.
Compared to an average industry Dividend Yield of 0.60, QIA has a dividend in line with its industry peers.
With a Dividend Yield of 0.55, QIA pays less dividend than the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y7.68%
EPS Next 3Y8.33%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (12/30/2025, 7:00:00 PM)

38.855

+0.1 (+0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2025-11-04/dmh
Earnings (Next)02-03 2026-02-03/amc
Inst Owners84.59%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.43B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.31%
PT rev (3m)-0.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE 19.24
Fwd PE 17.62
P/S 4.78
P/FCF 20.95
P/OCF 15.05
P/B 2.71
P/tB 12.41
EV/EBITDA 13.35
EPS(TTM)2.02
EY5.2%
EPS(NY)2.21
Fwd EY5.68%
FCF(TTM)1.85
FCFY4.77%
OCF(TTM)2.58
OCFY6.64%
SpS8.13
BVpS14.32
TBVpS3.13
PEG (NY)2.48
PEG (5Y)2.43
Graham Number25.51
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROCE 10.03%
ROIC 7.44%
ROICexc 10.67%
ROICexgc 39.98%
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
FCFM 22.82%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Debt/EBITDA 2.17
Cap/Depr 97.52%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 87.76%
Profit Quality 116.56%
Current Ratio 2.6
Quick Ratio 2.3
Altman-Z 3.49
F-Score8
WACC8.21%
ROIC/WACC0.91
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)8.18%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%4.04%
EPS Next Y7.77%
EPS Next 2Y7.68%
EPS Next 3Y8.33%
EPS Next 5Y9.41%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year4.96%
Revenue Next 2Y5.54%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.16%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%

QIAGEN N.V. / QIA.DE FAQ

What is the fundamental rating for QIA stock?

ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE.


Can you provide the valuation status for QIAGEN N.V.?

ChartMill assigns a valuation rating of 4 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.


How profitable is QIAGEN N.V. (QIA.DE) stock?

QIAGEN N.V. (QIA.DE) has a profitability rating of 7 / 10.


What is the financial health of QIAGEN N.V. (QIA.DE) stock?

The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.


Can you provide the expected EPS growth for QIA stock?

The Earnings per Share (EPS) of QIAGEN N.V. (QIA.DE) is expected to grow by 7.77% in the next year.